Since the first meeting in 2006, SFA²F evolves each year while maintaining focus on next generation sequencing technologies, applications, and their effect on the rapidly advancing field of genomics.
For registration and updates visit the SFAF Meeting website.
SFA2F Meetings emphasize
Genome Sequencing
- Sequencing strategies and technology advancements using the various NGS platforms
- De novo sequencing, re-sequencing, Human seq., RNA seq., metagenomics, etc.
- Sequencing applications for single cell, metagenomics, transcriptomics, diagnostics, and biosurveillance
Genome Assembly
- De novo assemblers for short reads, hybrid assemblers
- Recalling and calibrating genome assemblies
- Single cell and metagenomic assemblies
Genome Analysis
- Comparative genomics, re-sequencing, SNPs, structural variation
- Large scale data management, cloud computing
- Analysis for forensics, metagenomics, and antimicrobial resistance
Applications of Next Generation Sequencing
- Bringing sequence to the clinic (i.e., diagnostics, cancer, inherited disorders)
- Human, non-human, and infectious disease applications
- Gene editing, synthetic genomics, forensics, biosurveillance, and cyberbiosecurity
- AgriGenomics, livestock genomics, plant genomics
- Global engagement and partnerships
The SFA2F meeting offers unprecedented access to users and is very popular for vendors and users who are interested in close, practical interactions.
- >250 participants who are hands-on users of sequencing technology on a day-to-day basis.
- Attendees represent all areas of research, ranging from large genome centers and national labs, to smaller sequencing and analysis facilities.
- Access to key sequencing technology providers in a panel format and a fun round- table discussion.
- Presentation topics range from wet lab genomics techniques, data assembly, mapping, and analysis techniques to computer hardware and software solutions.
In order to enable a wide range of attendees and ensure a broad diversity of participants, we endeavor to keep registration fees at a minimum. Participants are responsible for a nominal registration fee, travel, and accommodations, but sponsors support nearly all meeting activities.
To learn about sponsorship opportunities, please contact Shawn Starkenburg at shawns@lanl.gov or Chris Detter at sfafmeeting@gmail.com, and we will add you to our list of satisfied contributors.
- Chris Detter, Ph.D., Principal Consultant, LBG and CSO, Definitive Biotech
- Johar Ali, Ph.D., Director Research, AA Ontario, Canada
- Patrick Chain, Ph.D, Staff Scientist and Lab Fellow, Los Alamos National Laboratory (LANL)
- Michael Fitzgerald, Microbial Special Projects Manager, Broad Institute
- Bob Fulton, M.S., Director of Development, Washington University
- Darren Grafham, Manager, Battelle UK limited
- Liliana Brown, Ph.D., Director Office of Genomics and Advanced Tech. at NIAID
- Alla Lapidus, Ph.D., Director, Center for Algorithmic Biotechnology SPbU, Russia
- Shawn Starkenburg, Ph.D., Deputy Group Leader, Biosecurity and Public Health Group, LANL
- Donna Muzny, M.Sc., Director of Operations, Baylor College of Medicine (BCM)
- Tootie Tatum, Ph.D., MBA, CEO Blackhawk Genomics
- Bin Hu, Ph.D., Staff Scientist, LANL
- Teresa Martinez Torres, Ph.D., Sr. Scientist, MRIGlobal
- Maryke Appel, Ph.D., Founder and President at EXO Consulting, LLC
- Kelly Hoon, Executive Sales Specialist, Illumina
- Kenny Yeh, Senior Science Advisor, MRIGlobal
- Kurt LaButti, Staff Data Scientist at Joint Genome Institute
- Shannon Johnson, Ph.D., Staff Scientist, LANL